TXMD - TherapeuticsMD, Inc.
2.3
0 0%
Share volume: 36,274
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.30
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-12-2024 | 11-12-2024 | 03-27-2025 | 05-13-2025 | 08-12-2025 | 11-12-2025 | |
| Assets | ||||||||
| Total Assets | 42.088 M | 40.126 M | 39.552 M | 38.822 M | 38.236 M | 38.504 M | 38.671 M | |
| Current Assets | 11.523 M | 11.823 M | 12.154 M | 12.259 M | 12.512 M | 13.461 M | 14.503 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 3.222 M | 2.908 M | 3.323 M | 3.562 M | 2.996 M | 3.743 M | 3.665 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 4.338 M | 5.232 M | 5.047 M | 5.059 M | 5.745 M | 6.069 M | 7.115 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 30.565 M | 28.303 M | 27.398 M | 26.563 M | 25.724 M | 25.043 M | 24.168 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 42.088 M | 40.126 M | 39.552 M | 38.822 M | 38.236 M | 38.504 M | 38.671 M | |
| Total liabilities | 13.424 M | 12.456 M | 12.458 M | 11.452 M | 11.496 M | 11.212 M | 11.227 M | |
| Total current liabilities | 6.468 M | 5.815 M | 5.976 M | 5.166 M | 4.741 M | 4.662 M | 4.945 M | |
| Accounts Payable | 2.859 M | 2.819 M | 3.052 M | 258.000 K | 176.000 K | 350.000 K | 263.000 K | |
| Other liabilities | 637.000 K | 637.000 K | 6.482 M | 6.286 M | 6.755 M | 6.550 M | 6.282 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 637.000 K | 637.000 K | 6.482 M | 6.286 M | 6.755 M | 6.550 M | 6.282 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 28.664 M | 27.670 M | 27.094 M | 27.370 M | 26.740 M | 27.292 M | 27.444 M | |
| Common stock | 979.039 M | 979.135 M | 979.168 M | 979.192 M | 979.215 M | 979.216 M | 979.216 M | |
| Retained earnings | -950.375 M | -951.465 M | -952.074 M | -951.822 M | -952.475 M | -951.924 M | -951.772 M |